Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: María Paulina Posada-Vergara
Format: Artículo científico
Sprache:en
Veröffentlicht: Universidad del Valle 2020
Schlagworte:
Online-Zugang:https://www.redalyc.org/articulo.oa?id=28364445009
https://www.redalyc.org/journal/283/28364445009/
https://www.redalyc.org/journal/283/28364445009/html/
https://www.redalyc.org/journal/283/28364445009/28364445009.epub
https://www.redalyc.org/journal/283/28364445009/movil
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866815411738116096
author María Paulina Posada-Vergara
author_facet María Paulina Posada-Vergara
contents COVID-19 and VIH María Paulina Posada-Vergara Juan Carlos Alzate-Ángel Ernesto Martínez-Buitrago Medicina 19 HIV COVID SARS virus coinfection Throughout the COVID-19 pandemic, the main risk factors associated with the progression to severe disease or death have been typically advanced age, diabetes mellitus, obesity, high blood pressure, heart disease, and chronic pneumopathy. Because of their immunosuppression status, persons with HIV were also expected to have a higher susceptibility to infection or a poor clinical evolution. So far, this has not been confirmed to happen, giving way to hypotheses about the role of immunosuppression or the use of antiretrovirals, which could explain this paradox. In this article we present the existing data on the epidemiology and characteristics of HIV-COVID-19 co-infection, discuss the available evidence on the possible factors involved in the evolution of individuals affected by both viruses, analyze other determinants that may negatively affect persons with HIV during the pandemic, and present recommendations for the prevention and care of COVID-19 infection in the context of HIV. 2020 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28364445009 https://www.redalyc.org/journal/283/28364445009/ https://www.redalyc.org/journal/283/28364445009/html/ https://www.redalyc.org/journal/283/28364445009/28364445009.epub https://www.redalyc.org/journal/283/28364445009/movil 10.25100/cm.v51i2.4327 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.2 Vol.51
format Artículo científico
id redalyc_28364445009
language en
publishDate 2020
publisher Universidad del Valle
spellingShingle COVID-19 and VIH
María Paulina Posada-Vergara
Medicina
19
HIV
COVID
SARS virus
coinfection
COVID-19 and VIH María Paulina Posada-Vergara Juan Carlos Alzate-Ángel Ernesto Martínez-Buitrago Medicina 19 HIV COVID SARS virus coinfection Throughout the COVID-19 pandemic, the main risk factors associated with the progression to severe disease or death have been typically advanced age, diabetes mellitus, obesity, high blood pressure, heart disease, and chronic pneumopathy. Because of their immunosuppression status, persons with HIV were also expected to have a higher susceptibility to infection or a poor clinical evolution. So far, this has not been confirmed to happen, giving way to hypotheses about the role of immunosuppression or the use of antiretrovirals, which could explain this paradox. In this article we present the existing data on the epidemiology and characteristics of HIV-COVID-19 co-infection, discuss the available evidence on the possible factors involved in the evolution of individuals affected by both viruses, analyze other determinants that may negatively affect persons with HIV during the pandemic, and present recommendations for the prevention and care of COVID-19 infection in the context of HIV. 2020 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28364445009 https://www.redalyc.org/journal/283/28364445009/ https://www.redalyc.org/journal/283/28364445009/html/ https://www.redalyc.org/journal/283/28364445009/28364445009.epub https://www.redalyc.org/journal/283/28364445009/movil 10.25100/cm.v51i2.4327 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.2 Vol.51
title COVID-19 and VIH
topic Medicina
19
HIV
COVID
SARS virus
coinfection
url https://www.redalyc.org/articulo.oa?id=28364445009
https://www.redalyc.org/journal/283/28364445009/
https://www.redalyc.org/journal/283/28364445009/html/
https://www.redalyc.org/journal/283/28364445009/28364445009.epub
https://www.redalyc.org/journal/283/28364445009/movil